title: Cytomegalovirus retinitis in acquired immunodeficiency syndrome patients: A problem worth giving attention to.
abstract: BACKGROUND
  Cytomegalovirus (CMV) retinitis remains the most common ocular opportunistic infection in patients with acquired immunodeficiency syndrome even in the era of highly active antiretroviral therapy (HAART). Increased survival of patients on HAART has increased incidence of blindness, which will further increase in the future. The objective of this study was to determine the incidence of CMV retinitis and the effect of HAART on the natural history of CMV retinitis in patients referred from ART center.
  
  
  METHODS
  Patients with baseline/current CD4 counts <150 cells/µl were evaluated for CMV retinitis. Complete ophthalmological evaluation was carried out and records of CD4 counts, HAART regime, presence of any form of CMV retinitis and response to HAART were noted.
  
  
  RESULTS
  Out of 800 patients registered with CD4 <150 cells/µl in ART center, 100 patients reached us. Among these, CMV retinitis was observed in 15% patients, with median CD4 count at the time of examination being 56 cells/µl (range: 24-306 cells/µl). 66.67% patients were HAART non-responders and 63.6% eyes were economically blind.
  
  
  CONCLUSIONS
  CMV retinitis occurs even in patients with higher CD4 counts. Timely diagnosis and intervention of this treatable condition can reduce the number of blinding years in these young patients who otherwise live longer as a result of HAART.
authors: Department of Ophthalmology, Government Medical College, Surat, Gujarat, India.
authors: Priti Kapadia
authors: PK
authors: Gupta
authors: Department of Ophthalmology, Government Medical College, Surat, Gujarat, India.
authors: Nikunj V
authors: NV
authors: Patel
authors: Department of Ophthalmology, Government Medical College, Surat, Gujarat, India.
authors: Shivani D
authors: SD
authors: Patel
authors: Department of Ophthalmology, Government Medical College, Surat, Gujarat, India.
authors: Kunjan J
authors: KJ
authors: Patel
keywords: Acquired immunodeficiency syndrome; CD4; cytomegalovirus retinitis; highly active antiretroviral therapy